TESING
logo
  • ABOUT US
    • Become a member
    • Contact Us
    • ERIC Structure
    • Make a Donation
    • Our Supporters
  • PROJECTS/PUBLICATIONS
    • Projects
    • Publications
    • Submit a Proposal
    • HARMONY
    • HARMONY – News
  • RECOMMENDATIONS
    • COVID-19 and CLL: FAQ’s
    • Inmunoglobin Gene Analysis
    • TP53 Aberrations
    • Minimal Residual Disease Detection
    • Allogeneic Stem Cell Transplant
  • DIAGNOSTICS
    • IG Network
    • TP53 Network
    • Expired Certifications
  • MEETINGS
    • Past ERIC Meetings
    • Upcoming Meetings
    • ERIC International Meeting
    • Abstracts
    • Invited Lectures
  • SURVEYS
    • TP53
    • COVID-19 Survey
  • PATIENTS
    • Educational Videos
    • General Information
    • Self-Management Tools
    • Test your Knowledge
  • ABOUT US
    • Become a member
    • Contact Us
    • ERIC Structure
    • Make a Donation
    • Our Supporters
  • PROJECTS/PUBLICATIONS
    • Projects
    • Publications
    • Submit a Proposal
    • HARMONY
    • HARMONY – News
  • RECOMMENDATIONS
    • COVID-19 and CLL: FAQ’s
    • Inmunoglobin Gene Analysis
    • TP53 Aberrations
    • Minimal Residual Disease Detection
    • Allogeneic Stem Cell Transplant
  • DIAGNOSTICS
    • IG Network
    • TP53 Network
    • Expired Certifications
  • MEETINGS
    • Past ERIC Meetings
    • Upcoming Meetings
    • ERIC International Meeting
    • Abstracts
    • Invited Lectures
  • SURVEYS
    • TP53
    • COVID-19 Survey
  • PATIENTS
    • Educational Videos
    • General Information
    • Self-Management Tools
    • Test your Knowledge

 6TH EDUCATIONAL IGCLL WORKSHOP

22-23 SEPTEMBER 2016 (UPPSALA, SWEDEN)

  • Welcome (L. Sutton)
  • B cell receptor signaling pathways in health and disease (D. Efremov)
  • Immunogenetics in CLL: the last 20 years (L. Sutton)
  • Mechanisms of immunoglobulin diversity (F. Davi)
  • From the patient to the sequence: Primers, PCR, Detection of clonality, Sequencing (A. Langerak)
  • IMGT tools for Interpretation of IG sequences and NGS repertoires: 2016 novelties (V. Giudicelli)
  • BcR IG Stereotyp: Identifying CLL subsets (A. Agathangelidis)
  • Hands on exercises (V. Bikos)
  • CLL genetics and prognostication (R. Rosenquist)
  • Targeting signaling pathways for treating CLL (P. Ghia)
  • Technical considerations for NGS analysis of immunoglublin gene repertoires (A. Vardi)
  • Bioinformatics: State-of-art tools for NGS immunogenetics (N. Darzentas)
  • MRD in CLL (A. Rawstron)
  • ERIC Executive Office
    C/ Sant Antoni M. Claret, 167
    Pabellón 18, Despacho 38
    08025, Barcelona (Spain)
    office@ericll.org
    Tel:+34 938823878
  • Board

    Contact us

    Membership

    Personal Data Protection 

© Copyright by ERIC